Nutrition and Cancer: Further Case Studies Involving Salvestrol

by Brian A. Schaefer, D.Phil.; Catherine Dooner, BA, M.; Danny Burke, PhD; and Gerard A. Potter, PhD
Source: Health Action, Winter 2010

A nutritional approach to the treatment of cancer can provide great benefit to patients. The ­nutritional approach focused on through the following case studies, published in the Journal of Orthomolecular Medicine (Vol. 25 No. 1, 2010), addresses deficiencies in dietary phytonutrients known as Salvestrols along with their co-factors.

Salvestrols operate through a ­highly targeted mechanism that hinges on their metabolism by the universal cancer ­marker CYP1B1. This results in a very broadly applicable method in addressing a nutritional deficiency to the benefit of patients. Unfortunately modern farming practices have severely limited the availability of these specific phytonutrients in the modern diet. These phytonutrients are all phytoalexins and are not induced in abundance until the plant comes under ­attack from infection or predation.

In the journal article six cases of ­recovery from cancer using this ­nutritional approach were discussed. Here are two of those cases, which are amazing and ­inspiring stories.

Stage 3 breast cancer
A 50-year-old female presented to her physician with pain in her upper chest area and tiredness. She was subsequently diagnosed with stage 3 breast cancer following ultrasound imaging. The diagnosis was confirmed through biopsy. Imaging revealed a 2.5-centimetre tumour in the left breast. She had a concurrent diagnosis of hypothyroidism.

Surgical removal of the tumour, along with chemotherapy and radiotherapy, were recommended. ­Chemotherapy was declined and a surgery date was scheduled for exactly one month after the diagnosis had been confirmed. In the interim, pain was managed with Tylenol 3 (two tablets at onset of pain).

Concurrent with obtaining the diagnosis, the patient began a course of Salvestrols. This comprised five Salvestrol Professional (350 point) capsules and five Salvestrol Gold (350 point) capsules, spread through the day by taking a ­roughly equal number of capsules before each of the three main meals. This ­level of Salvestrol supplementation (3,500 points per day) was carried out for three months.

Further to the Salvestrol supplementation, the patient embarked on an ­organic, vegan diet (vegetables, greens, fruits, juices, wheatgrass and tea) and an exercise program of walking and yoga. Salvestrol specific co-factors were also taken: biotin, 300 mcg; niacin, amount unknown; magnesium by way of a calcium/magnesium tablet, amount unknown; iron, 1 oz., amount unknown; and vitamin C, 1,000 mg. In addition, her naturopathic physician added selenium (200 mg) to her daily supplementation.

During the one-month wait for surgery, breast self-examination revealed that the tumour softened, the texture changed and the tumour progressively decreased in size. Surgery removed a 1.3 cm tumour (about half the diameter of the tumour at time of diagnosis one month earlier). The lymph nodes were free of cancer, as was the blood. A hematology panel showed all results were within normal limits. One month after surgery, the patient received radiotherapy once a day for 30 days, as a preventive measure.

After three months of Salvestrol supplementation, the dosage was reduced to a total of six capsules per day. This comprised three Salvestrol Professional (350 point) capsules and three Salvestrol Gold (350 point) capsules, spread through the day by taking one capsule of each before each main meal. This level of Salvestrol supplementation (2,100 points per day) has been maintained.

Eight months after surgery the patient was cancer free, pain free and experiencing less tiredness. At 13 months after surgery, the patient remains cancer free, pain free and experiencing little tiredness. Her diagnosis of hypothyroidism remains. It seems reasonable to conclude that the degree of tumour shrinkage that she experienced during the one-month wait for surgery is attributable to the Salvestrol supplementation, her focus on nutrition, exercise and Salvestrol co-factor supplementation.

Stage 2 liver cancer
A 73-year-old Korean male was diagnosed with second-stage liver cancer following a scheduled examination to monitor his alcohol-related liver cirrhosis. The patient had lost a lot of weight and had noticed an unusual odour associated with bowel movements. A CT scan revealed three tumours: one in the centre of the liver in damaged tissue and two in healthy portions of his liver.

No chemotherapy or radiotherapy treatment was prescribed due to the patient's age, the number of liver tumours and his concurrent conditions, as he suffered from both cirrhosis of the liver and pulmonary tuberculosis. In an attempt to downstage the tumours, a hepatic artery embolisation was performed.

One month following his diagnosis he began taking 12 (350 point) Salvestrol supplements per day, commensurate with his body weight. This comprised six Salvestrol Professional (350 point) capsules and six Salvestrol Gold (350 point) capsules, spread through the day by taking two of each capsule after each main meal. This level of Salvestrol supplementation (4,200 points per day) was maintained for four months. The level of supplementation was then lowered to six (350 point) Salvestrol supplements per day, comprising three Salvestrol Professional capsules and three Salvestrol Gold capsules (2,100 points per day).

In addition to the Salvestrol supplementation, he began receiving intravenous vitamin C injections starting at 30 grams per week. This dose was increased through the following weeks moving in large increments until reaching 100 grams per week. This level was maintained for six months before it was reduced to an ongoing weekly injection of 40 grams. Niacin was also added to his regimen about four months after his diagnosis. He initially took 250 milligrams per day for one month and then increased this amount to 500 milligrams per day for about five months. There were no significant dietary changes; however, he did commence a program of breathing exercises, chi exercises, meditation, stretching and stress avoidance.

Due to the variety of conditions that he suffered from, he received ongoing medical examinations. Eleven months after commencing Salvestrol supplementation he was declared "all clear."

Although the patient still suffers from pulmonary tuberculosis and liver cirrhosis, he says he feels very comfortable. Given that hepatic artery embolisation is not a curative procedure, this case leaves Salvestrol supplementation, high dose vitamin C, niacin, exercise and mental outlook as the possible candidates to explain his recovery. He provides the following message: "Confidence and belief of being cured is important. People say everything comes from mind. Therefore, I think positive and stable mind is very important. I think we all need confidence that we can overcome any diseases. Anyone can do it!"

These cases are brought to light here in the hope that they will provide cancer sufferers and their physicians with the confidence to explore nutritional approaches before, or concurrent with, conventional procedures to achieve a beneficial outcome.
 
 
. .